|
|
Volumn 11, Issue 5, 2004, Pages 583-587
|
|
Targeting Bcl-XL in esophageal squamous cancer to sensitize to chemotherapy plus TRAIL-induced apoptosis while normal epithelial cells are protected by blockade of caspase 9
a,b,c,d
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CASPASE 8;
CASPASE 9;
DOXORUBICIN;
PROTEIN BAX;
PROTEIN BID;
TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;
APOPTOSIS REGULATORY PROTEIN;
BCL2L1 PROTEIN, HUMAN;
CASP9 PROTEIN, HUMAN;
CASPASE;
MEMBRANE PROTEIN;
PROTEIN BCL 2;
PROTEIN BCL X;
TNFSF10 PROTEIN, HUMAN;
TUMOR NECROSIS FACTOR ALPHA;
APOPTOSIS;
CELL TYPE;
ENZYME ACTIVATION;
ENZYME ACTIVITY;
ENZYME INHIBITION;
ESOPHAGUS CANCER;
FLOW CYTOMETRY;
IMMUNOHISTOCHEMISTRY;
LETTER;
MOUSE;
NONHUMAN;
OLIGOMERIZATION;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
PROTEIN LOCALIZATION;
PROTEIN TARGETING;
SIGNAL TRANSDUCTION;
SQUAMOUS CELL CARCINOMA;
WESTERN BLOTTING;
DRUG EFFECT;
DRUG THERAPY;
EPITHELIUM CELL;
ESOPHAGUS TUMOR;
HUMAN;
METABOLISM;
APOPTOSIS;
APOPTOSIS REGULATORY PROTEINS;
BCL-X PROTEIN;
CASPASE 9;
CASPASES;
DRUG THERAPY;
EPITHELIAL CELLS;
ESOPHAGEAL NEOPLASMS;
HUMANS;
MEMBRANE GLYCOPROTEINS;
PROTO-ONCOGENE PROTEINS C-BCL-2;
TNF-RELATED APOPTOSIS-INDUCING LIGAND;
TUMOR NECROSIS FACTOR-ALPHA;
|
|
EID: 2542466894
PISSN: 13509047
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.cdd.4401388 Document Type: Letter |
|
Times cited : (20)
|
|
References (21)
|
